Table 2.
Study | n | CAD Prevalence (%) | Sensitivity (%) | Specificity (%) | PPV | NPV |
---|---|---|---|---|---|---|
Pennell et al35 | 40 | 98 | 62 | 100 | 100 | 52 |
Pennell et al36 | 25 | 88 | 91 | 100 | 100 | 60 |
van Rugge et al37 | 45 | 82 | 81 | 100 | 100 | 53 |
Baer et al38 | 32 | 100 | 84 | NA | NA | NA |
van Rugge et al39 | 39 | 85 | 91 | 83 | 97 | 63 |
Nagel et al40 | 172 | 63 | 86 | 86 | 91 | 78 |
Hundley et al41 | 41 | 85 | 83 | 83 | 97 | 45 |
Schalla et al17,‡ | 22 | 73 | 81 | 83 | 93 | 63 |
Paetsch et al42 | 79 | 67 | 89 | 80 | 91 | 77 |
Paetsch et al47,* | 150 | 51 | 78 | 87 | 87 | 79 |
Wahl et al43 | 160 | 74 | 89 | 84 | 94 | 73 |
Jahnke et al44 | 40 | 70 | 89 | 83 | 93 | 77 |
Gebker et al45 | 455 | 69 | 85 | 82 | 91 | 71 |
Korosoglou et al33,† | 80 | 58 | 98 | 85 | 90 | 97 |
Meta-analysis | ||||||
Nandalur et al46 | 735 | 70.5 | 83 | 86 | 93 | 68 |
Abbreviations: NA, not available; NPV, negative predictive value; PPV, positive predictive value.
Mean values reported from 4 independent readers.
Strain-encoded cardiac magnetic resonance imaging used.
Real-time cardiac magnetic resonance imaging used.